FDA approved PFS-based autoinjectors: evolution, market trends, and development challenges
Furthermore, the technical challenges in incorporating injectable formulations into spring-driven autoinjector systems are discussed. This review aims to facilitate the development of safer, more efficient autoinjector platforms that enhance user experience and treatment adherence.
Authors
- Wei Chen (ORCID: https://orcid.org/0000-0002-7614-4436)
- Duoduo Zhang (ORCID: https://orcid.org/0009-0008-4112-4145)
- Shunying Ji (ORCID: https://orcid.org/0000-0002-1618-441X)
- Jeremy Guo (ORCID: https://orcid.org/0000-0002-2497-9642)
- Jun Yan (ORCID: https://orcid.org/0000-0003-1373-4380)
- Xuejun Gu
- Yueming Sun
Institutions
- WuXi AppTec (China) (CN)
Publication Details
- Journal
- Expert Opinion on Drug Delivery
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1080/17425247.2025.2585166
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00